Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

ERSOY, BETÜL; Eroglu, Nilgun; Cetin, Mecnun; ONUR, ECE; ÖZKOL, MİNE; COŞKUN, ŞENOL

doi:10.1177/1479164118757921

Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

ERSOY B., Eroglu N., Cetin M., ONUR E., ÖZKOL M., COŞKUN Ş.

DIABETES & VASCULAR DISEASE RESEARCH, vol.15, no.3, pp.196-203, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 15 Issue: 3
Publication Date: 2018
Doi Number: 10.1177/1479164118757921
Journal Name: DIABETES & VASCULAR DISEASE RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.196-203
Open Archive Collection: AVESIS Open Access Collection
Karadeniz Technical University Affiliated: Yes

Abstract

Aims: We aimed to evaluate asymmetric dimethylarginine levels in young patients with Type 1 diabetes mellitus according to diabetes duration and to examine the relationship between these levels and measures of atherosclerosis and myocardial function.